In paroxysmal AF, first-line catheter ablation vs. antiarrhythmic drugs reduces atrial arrhythmia recurrence

Area of Science:

• Cardiology
• Electrophysiology
• Medical Interventions

Background:

• Paroxysmal atrial fibrillation (AF) is a common arrhythmia.
• Current guidelines often recommend antiarrhythmic drugs as initial therapy.
• The role of catheter ablation as a first-line treatment for AF requires further investigation.

Purpose of the Study:

• To systematically review and meta-analyze existing evidence on catheter ablation as a first-line treatment for paroxysmal atrial fibrillation.
• To compare the efficacy and safety of early catheter ablation versus conventional treatment strategies.

Main Methods:

• Systematic literature search of randomized controlled trials and observational studies.
• Meta-analysis of data on procedural success, recurrence of atrial fibrillation, and adverse events.
• Assessment of quality of evidence and potential biases.

Main Results:

• Catheter ablation demonstrated a significantly higher success rate in maintaining sinus rhythm compared to antiarrhythmic drugs.
• First-line ablation was associated with a lower risk of AF recurrence and fewer treatment-related side effects.
• No significant difference in major adverse cardiac and cerebrovascular events was observed between the groups.

Conclusions:

• Catheter ablation represents a safe and highly effective first-line therapeutic option for patients with paroxysmal atrial fibrillation.
• Early adoption of catheter ablation may improve long-term outcomes and patient quality of life.
• Consideration of catheter ablation as an initial treatment strategy is warranted.